All In Biotech

Drug Trial Radar · NCT05046106

MLC1501 Study Assessing Efficacy in STROke Recovery

A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Efficacy and Safety Study of MLC1501 in Patients With Stroke

Last checked: Nov 19, 2026Latest source record: Mar 16, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingPhase 3. Randomized with 540 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

540

Planned (sponsor's estimate)

Start

Jan 2025

Primary completion

Sep 2028

Study completion Dec 2028

Sponsor

Lead sponsor
Moleac Pte Ltd.Industry
Sponsor type
Industry
First posted
Sep 16, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multi-center, randomized, double-blind, placebo-controlled, dose-response study of MLC1501 in patients with stroke. Eligible participants will be randomized in a 1:1:1 ratio to orally receive MLC1501 low-dose twice a day, MLC1501 high-dose twice a day, or matching placebo for 24 weeks.

Conditions

  • Stroke
  • Stroke, Ischemic
  • Strokes Thrombotic
  • Stroke Sequelae
  • Stroke, Cardiovascular
  • Stroke, Embolic
  • Stroke, Cryptogenic

Interventions

  • MLC1501Drug

    Powdered extract of Radix astragali, Rhizoma chuanxiong, Radix angelica sinensis, Radix polygala

  • PlaceboOther

    Caramel, chocolate brown, flavor (E\_1982648), dextrin

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. modified Rankin ScaleTime frame: 24 weeks

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.